SPON2 and neoplasm: Furthermore, in a mouse model of LIHC, they observed upregulation of SPON2 along with activation of the WNT/β-catenin and Hippo/Yap signaling pathways, leading to hepatomegaly, enhanced tumor formation, and accelerated progression of LIHC (55).